Clinical Trials Directory

Trials / Completed

CompletedNCT01801254

Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The field of neuroeconomics has begun to elucidate neural mechanisms underlying self-control; however, researchers have not yet harnessed neuroeconomics findings to develop interventions for improving self-control ability. The investigators are currently developing such an intervention. The investigators' approach involves using a brain-computer interface with audiovisual feedback to show people what is happening in their own brains, in real time. Through this interface, individuals are trained to increase levels of neural activity that may facilitate self-control, which, in turn, may improve the ability to exhibit self-controlled behaviors. This may increase the ability to engage in heath behaviors for which self-control is required (eg, dieting and exercising). The investigators' long-term goal is to create a tool that will help people develop the self-control needed to achieve lasting improvements in health behaviors.

Conditions

Interventions

TypeNameDescription
OTHERSTRIDESSelf-Control TRaining for Increasing Delay of gratification through EEG operant conditioning with Source localization (STRIDES). Brain-computer interface training protocol designed to up-regulate specific types of neural activity, in regions including the left dorsolateral prefrontal cortex, the anterior cingulate cortex, and Brodmann area 6 bilaterally. Targeted neural activity types are positively associated with self-controlled behavior.
OTHERSham ControlBrain-computer interface training protocol that is designed to have no effect on self-controlled behavior.

Timeline

Start date
2013-02-01
Primary completion
2013-08-01
Completion
2015-02-01
First posted
2013-02-28
Last updated
2015-04-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01801254. Inclusion in this directory is not an endorsement.